Literature DB >> 15086344

A novel polymorphism in the cytoplasmic region of the human immunoglobulin A Fc receptor gene.

M Jasek1, M Mańczak, A Sawaryn, A Obojski, A Wiśniewski, W Łuszczek, P Kuśnierczyk.   

Abstract

The Fc receptor for immunoglobulin A (IgA), FcalphaRI, is expressed on several types of myeloid cells, and activates them upon ligand binding. However, binding of IgA to the extracellular domain of the receptor requires previous stimulation of the cell by cytokines, and the cytoplasmic tail of FcalphaRI has been shown to play a role in this. Therefore, polymorphism in this region might affect this process. However, no changes in the amino acid sequence in this region of the FcalphaRI have so far been reported. Here, we describe for the first time a single nucleotide polymorphism in exon 5 of the immunoglobulin A Fc receptor (FCAR) gene leading to a Ser-->Gly substitution at position 248 of the mature FcalphaRI protein. Prediction of structural features suggests some changes that may affect the function of the protein to some extent. However, the Gly248 variant is quite common (4% homozygotes and 38% heterozygotes) in healthy population, suggesting a weak effect, if any, on function, at least in heterozygotes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086344     DOI: 10.1111/j.1365-2370.2004.00445.x

Source DB:  PubMed          Journal:  Eur J Immunogenet        ISSN: 0960-7420


  3 in total

Review 1.  Functional and clinical consequences of Fc receptor polymorphic and copy number variants.

Authors:  S Bournazos; J M Woof; S P Hart; I Dransfield
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

Review 2.  Immunoglobulin A: A next generation of therapeutic antibodies?

Authors:  Jantine E Bakema; Marjolein van Egmond
Journal:  MAbs       Date:  2011-07-01       Impact factor: 5.857

Review 3.  Human FcR polymorphism and disease.

Authors:  Xinrui Li; Andrew W Gibson; Robert P Kimberly
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.